CG
AXSM icon

Cutler Group’s Axsome Therapeutics AXSM Stock Holding History

Cutler Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$12K Sell
1,000
-2,400
-71% -$201K ﹤0.01% 1201
2023
Q4 		$28K Sell
3,400
-2,400
-41% -$160K ﹤0.01% 1765
2023
Q3 		$35K Hold
5,800
– – ﹤0.01% 1683
2023
Q2 		$37K Buy
5,800
+400
+7% +$29.5K 0.01% 1473
2023
Q1 		$29K Sell
5,400
-3,900
-42% -$256K ﹤0.01% 1696
2022
Q4 		$96K Sell
9,300
-7,100
-43% -$424K 0.01% 1173
2022
Q3 		$16K Sell
16,400
-3,400
-17% -$170K ﹤0.01% 2757
2022
Q2 		$106K Buy
19,800
+5,200
+36% +$164K 0.01% 1413
2022
Q1 		$79K Buy
14,600
+300
+2% +$9.3K ﹤0.01% 1872
2021
Q4 		$54K Sell
14,300
-10,800
-43% -$397K ﹤0.01% 2341
2021
Q3 		$89K Buy
25,100
+22,100
+737% +$861K ﹤0.01% 2010
2021
Q2 		$30K Sell
3,000
-300
-9% -$18K ﹤0.01% 2932
2021
Q1 		$27K Sell
3,300
-1,000
-23% -$70.3K ﹤0.01% 2927
2020
Q4 		$71K Sell
4,300
-5,100
-54% -$381K ﹤0.01% 1754
2020
Q3 		$79K Buy
9,400
+7,900
+527% +$616K ﹤0.01% 1468
2020
Q2 		$30K Sell
1,500
-11,200
-88% -$862K ﹤0.01% 2088
2020
Q1 		$40K Sell
12,700
-43,800
-78% -$3.57M ﹤0.01% 1858
2019
Q4 		$3.08M Buy
56,500
+46,700
+477% +$1.89M 0.19% 94
2019
Q3 		$17K Sell
9,800
-20,500
-68% -$527K ﹤0.01% 2286
2019
Q2 		$207K Buy
30,300
+19,900
+191% +$399K 0.02% 696
2019
Q1 		$15K Buy
+10,400
New +$96.6K ﹤0.01% 2208

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cutler Group's AXSM Position: Q1 2024 in Review

Cutler Group reduced its Axsome Therapeutics (AXSM) stake by 67% in Q1 2024, selling an estimated $33.6K and leaving 200 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #1106.

Cutler Group first reported a position in AXSM in Q1 2019 and has held it in 20 quarters since. The position peaked at $771K in Q4 2021. 259 funds tracked by Wall St. Rank hold AXSM as of Q1 2024.

  • Cutler Group held 200 shares of Axsome Therapeutics worth $15K as of Q1 2024.
  • Cutler Group sold 400 Axsome Therapeutics shares in Q1 2024, an estimated $33.6K.
  • Axsome Therapeutics made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1106 holding.
  • Cutler Group first reported a position in Axsome Therapeutics in Q1 2019 and has held it in 20 quarters since.
  • Cutler Group's Axsome Therapeutics position peaked at $771K in Q4 2021.
  • 259 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.